# Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial

> **NCT03571776** · NA · TERMINATED · sponsor: **Hospital Universitari de Bellvitge** · enrollment: 158 (actual)

## Conditions studied

- Endometrioma
- Fertility Disorders

## Interventions

- **PROCEDURE:** Surgery
- **PROCEDURE:** Sclerotherapy

## Key facts

- **NCT ID:** NCT03571776
- **Lead sponsor:** Hospital Universitari de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-06-05
- **Primary completion:** 2023-01-15
- **Final completion:** 2023-01-15
- **Target enrollment:** 158 (ACTUAL)
- **Why stopped:** Low recruitment because patients and gynecologists prefer the sclerosis arm to avoid surgery
- **Last updated:** 2023-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03571776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03571776, "Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03571776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*